About Careers MedBlog Contact us

Cymbalta Gets Approval for Use in Europe

by Savitha C Muppala on August 23, 2008 at 7:07 PM
Font : A-A+

 Cymbalta Gets Approval for Use in Europe

Cymbalta, the drug manufactured by Eli Lilly is now legally approved to be marketed in Europe.

The drug is used as treatment for generalized anxiety disorder where the victim experiences a great deal of worry and anxiety. Anxiety disorder is known to afflict 9 million people in Europe.


The drug had earlier been approved for use to alleviate severe depressive disorder and neuropathic pain.

For instance, in the United States, the drug was used to treat anxiety diabetic nerve pain, major depressive disorder and fibromyalgia.

Sales for this drug had touched $2.1 billion in 2007. Shares of Eli Lilly has shown progress, up by 1.7%.

Source: Medindia


Latest Drug News

 FDA Issues Warning About Compounded Diabetes Drug Semaglutide Products
The FDA advises consumers not to use compounded medications as an alternative to known diabetic and weight reduction medications Ozempic, Rybelsus, and Wegovy.
 Parkinson's Unmet Needs Creates Path for New Entrants into the Market
Addressing the unmet needs of Parkinson's Disease by providing disease-modifying therapies could bring about a major shift in the way that patients are treated.
How Microrobots Could Help Treat Bladder Diseases?
Microrobots could swirl through a person's blood stream, search for targeted areas to treat for various ailments.
How Can Multivitamin Supplements Slow Cognitive Aging?
Supplementation with multivitamins is an inexpensive way for older adults to slow down memory loss.
 Ivosidenib Approved for Acute Myeloid Leukemia & Advanced Cholangiocarcinoma
Some people with an aggressive blood cancer called acute myeloid leukemia (AML) may soon have a new drug option called Ivosidenib that blocks the activity of IDH1 gene.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

Cymbalta Gets Approval for Use in Europe Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests